Arkolith/Insider Trading/RPTX/Form 4

Segal Lloyd Mitchell

PRESIDENT AND CEO, DirectorRepare Therapeutics Inc. (RPTX) · full profile →Form 4 · filed Mar 27, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$37K
Net Open-Market Flow
-$37K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 27, 2024Sell(S)3K$4.63$12K84K
Mar 26, 2024Sell(S)3K$4.64$12K87K
Mar 25, 2024Sell(S)3K$4.79$13K89K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-009249) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML